Page last updated: 2024-11-06

alloxan and Immunologic Deficiency Syndromes

alloxan has been researched along with Immunologic Deficiency Syndromes in 1 studies

Alloxan: Acidic compound formed by oxidation of URIC ACID. It is isolated as an efflorescent crystalline hydrate.
alloxan : A member of the class of pyrimidones, the structure of which is that of perhydropyrimidine substituted at C-2, -4, -5 and -6 by oxo groups.

Immunologic Deficiency Syndromes: Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.

Research Excerpts

ExcerptRelevanceReference
"Treatment of alloxan-diabetic mice with insulin in vivo completely reversed all immune defects, while insulin treatment of streptozotocin-diabetic mice restored immune function to only 70-80% of normal levels."1.27Assessment of the diabetogenic drugs alloxan and streptozotocin as models for the study of immune defects in diabetic mice. ( Eardley, DD; Gaulton, GN; Schwartz, JL, 1985)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gaulton, GN1
Schwartz, JL1
Eardley, DD1

Other Studies

1 other study available for alloxan and Immunologic Deficiency Syndromes

ArticleYear
Assessment of the diabetogenic drugs alloxan and streptozotocin as models for the study of immune defects in diabetic mice.
    Diabetologia, 1985, Volume: 28, Issue:10

    Topics: Alloxan; Animals; Antibody Formation; B-Lymphocytes; Diabetes Mellitus, Experimental; Disease Models

1985